Mindset Pharma Inc.
Mindset Pharma Inc. is a drug discovery and development company focused on creating optimized and patentable best-in-class innovative next-generation psychedelic medicines to treat neurological and psychiatric disorders with unmet needs. Mindset was established in order to develop next-generation pharmaceutical assets that leverage the breakthrough therapeutic potential of psychedelic drugs. Mindset is developing several novel families of next-generation psychedelic compounds, as well as an innovative process to chemically synthesize psilocybins in addition to its own proprietary compounds. The company has a co-development agreement with the McQuade Center for Strategic Research and Development, a member of the Otsuka Pharmaceuticals family of companies, covering multiple drug development programs.
Address |
217 Queen Street West Suite 401 Toronto, ON M5V 0R2 Canada |
---|---|
Phone |
1 +416-479-4094 |
Website |
https://www.mindsetpharma.com |
Industry |
Biotech/Healthcare |
Listings |
CNSX-MSET, OTCQB-MSSTF, FSE-9DF |
Key Executives |
James Lanthier, CEO |